1. Home
  2. APGE vs SLVM Comparison

APGE vs SLVM Comparison

Compare APGE & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SLVM
  • Stock Information
  • Founded
  • APGE 2022
  • SLVM 1898
  • Country
  • APGE United States
  • SLVM United States
  • Employees
  • APGE N/A
  • SLVM N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SLVM Paper
  • Sector
  • APGE Health Care
  • SLVM Basic Materials
  • Exchange
  • APGE Nasdaq
  • SLVM Nasdaq
  • Market Cap
  • APGE 2.1B
  • SLVM 2.4B
  • IPO Year
  • APGE 2023
  • SLVM N/A
  • Fundamental
  • Price
  • APGE $36.64
  • SLVM $52.94
  • Analyst Decision
  • APGE Strong Buy
  • SLVM Hold
  • Analyst Count
  • APGE 4
  • SLVM 3
  • Target Price
  • APGE $91.33
  • SLVM $85.67
  • AVG Volume (30 Days)
  • APGE 589.2K
  • SLVM 338.3K
  • Earning Date
  • APGE 05-12-2025
  • SLVM 05-09-2025
  • Dividend Yield
  • APGE N/A
  • SLVM 3.40%
  • EPS Growth
  • APGE N/A
  • SLVM 45.44
  • EPS
  • APGE N/A
  • SLVM 6.82
  • Revenue
  • APGE N/A
  • SLVM $3,689,000,000.00
  • Revenue This Year
  • APGE N/A
  • SLVM N/A
  • Revenue Next Year
  • APGE $743.14
  • SLVM $0.14
  • P/E Ratio
  • APGE N/A
  • SLVM $7.76
  • Revenue Growth
  • APGE N/A
  • SLVM 0.11
  • 52 Week Low
  • APGE $26.20
  • SLVM $51.60
  • 52 Week High
  • APGE $63.50
  • SLVM $98.02
  • Technical
  • Relative Strength Index (RSI)
  • APGE 44.68
  • SLVM 37.44
  • Support Level
  • APGE $39.00
  • SLVM $54.32
  • Resistance Level
  • APGE $38.04
  • SLVM $55.70
  • Average True Range (ATR)
  • APGE 1.91
  • SLVM 1.53
  • MACD
  • APGE -0.46
  • SLVM -0.03
  • Stochastic Oscillator
  • APGE 14.32
  • SLVM 8.19

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.

Share on Social Networks: